Hyundai Motor had exported two Nexo FCEVs and two Elec City fuel cell electric buses from Ulsan to Saudi Arabia, marking its first-ever fuel cell electric vehicles (FCEV) exports to the Middle East.
The four FCEVs will be delivered to state-run oil firm Saudi Aramco and will be used for test drives to verify its economic feasibility.
According to Hyundai Motor Vice President of the Middle East and African region Jeong Bang-sun, exporting FCEVs to the world’s top oil producer is a meaningful step and they intend to expand the supply of FCEVs in the Middle East.
Hyundai Motor and Saudi Aramco signed a memorandum of understanding in June last year to roll out more FCEVs in Saudi Arabia.
Saudi Arabia is the first country that Hyundai has exported Elec City FCEVs to.
Nexo can run about 609 kilometers on a single charge, while Elec City could cover 430 kilometers.


Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



